Search

Author/Creator De la Cruz-Merino, L.

1. 25LBA Impact of baseline genetic heterogeneities on progression-free survival (PFS) in patients (pts) with advanced BRAFV600-mutated melanoma treated with cobimetinib (COBI) + vemurafenib (VEM) in the phase 3 coBRIM study. (September 2015)

Authors:
McArthur, G.; Larkin, J.; Dréno, B.; Ascierto, P.; Liszkay, G.; Maio, M.; Mandal´, M.; Demidov, L.; Stroyakovskiy, D.; Thomas, L.; De la Cruz-Merino, L.; Atkinson, V.; Dutriaux, C.; Garbe, C.; Wongchenko, M.; Hsu, J.; Koralek, D.; Rooney, I.; Yan, Y.; Ribas, A.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S722
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search